L2 Capital Announces Exciting Exit: Aspekt Solutions Joins Varian's Siemens Healthineers Team

L2 Capital is thrilled to announce the successful sale of Aspekt Solutions, a leading provider of medical physics, dosimetry, and strategy consultation services, to Varian, a Siemens Healthineers company. This transaction represents a significant milestone for L2 Capital and showcases their expertise in transforming niche market leading businesses into mass market solutions. Under L2's ownership, Aspekt Solutions underwent remarkable growth and development, positioning the company for rapid expansion and success.

During L2 Capital's investment in Aspekt Solutions, the company experienced substantial corporate leadership changes and executed a transformative acquisition. These strategies, coupled with the implementation of a focused strategic plan, allowed Aspekt Solutions to grow its core clinical medical physics services business, broaden its product portfolio, expand its geographic reach, and establish a solid foundation for future growth.

Connor McMahan, Partner at L2 Capital, expressed his pride in the team's accomplishments and emphasized the collaborative approach taken with founders. McMahan stated, "This successful exit illustrates how our team collaborates with founders and transforms niche market leading businesses into mass market solutions. We are very proud of what we have accomplished together."

The addition of a new CEO with a proven track record in healthcare played a vital role in Aspekt Solutions' success under L2 Capital's ownership. The leadership team worked closely with the CEO to strategize and achieve breakthrough goals, ensuring the company had the necessary resources and investment for growth. With the support of L2 Capital, Aspekt Solutions became a market leader, delivering best-in-class outcomes for clinics and patients.

Brian Pellegrini, CEO of Aspekt Solutions, expressed his gratitude for L2 Capital's support and collaborative approach. He stated, "I appreciate the support and collaborative approach L2 Capital takes. I felt I had a true partner in L2 to strategize and achieve the breakthrough goals we set together." Pellegrini also expressed his excitement for the new chapter as part of Varian and the Siemens Healthineers team, anticipating an acceleration of their positive impact.

Troutman Pepper served as legal counsel to L2 Capital during the transaction, ensuring a smooth and successful exit for Aspekt Solutions.

About Aspekt Solutions

Aspekt Solutions is dedicated to supporting radiology and radiation oncology providers by providing them with the staff, guidance, technical expertise, and operational support to turn a high-risk, high-capital business into a competitive advantage. The company's mission is to make a difference one patient, one clinic, one system at a time. Aspekt Solutions achieves this by assembling a team of top physicists, dosimetrists, and strategy consultants, closely partnering with clients to enhance their existing programs and prepare them for the future.

About L2 Capital

L2 Capital is a private equity firm specializing in the lower middle market. With offices in Devon, PA, and Miami, FL, L2 Capital focuses on delivering market-leading returns by investing in niche lower middle market consumer and business services companies. The firm's operations-focused strategy targets founder and entrepreneur-led businesses that are at an inflection point, allowing L2 Capital to utilize their breakthrough growth framework and direct operating expertise to drive rapid market share gain.

About Varian

Varian, a Siemens Healthineers company, envisions a world without fear of cancer. With over 75 years of experience, Varian has developed innovative technologies and solutions that help care providers worldwide treat millions of patients each year. As part of Siemens Healthineers, Varian supports the entire cancer care journey, from screening to survivorship. Their comprehensive range of products includes advanced imaging and radiation therapy, comprehensive software and services, and interventional radiology. Varian is committed to creating a more efficient and personalized care pathway for cancer patients globally.

For more information about Varian, visit http://www.varian.com.

In conclusion, L2 Capital's successful sale of Aspekt Solutions to Varian, a Siemens Healthineers company, highlights their ability to transform businesses and drive exceptional growth. The partnership between L2 Capital and Aspekt Solutions resulted in significant advancements, establishing the company as a leader in the medical physics industry. With the support of Varian's global platform, Aspekt Solutions is poised for even greater success in delivering exceptional clinic and patient outcomes.